|
|
| Model Number |
PPM1515X3 |
| Medical Device Problem Codes |
Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
|
| Health Effect - Clinical Codes |
Abscess (1690); Adhesion(s) (1695); Purulent Discharge (1812); Fever (1858); Foreign Body Reaction (1868); Hematoma (1884); Unspecified Infection (1930); Inflammation (1932); Ischemia (1942); Nausea (1970); Pain (1994); Perforation (2001); Scar Tissue (2060); Vomiting (2144); Distress (2329); Impaired Healing (2378); Obstruction/Occlusion (2422); Fluid Discharge (2686); Cramp(s) /Muscle Spasm(s) (4521); Unspecified Tissue Injury (4559); Swelling/ Edema (4577); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
H6, ime e2402: sinus tract, subserosal congestion, weight loss medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
The patient's attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an epigastric incisional hernia.It was reported that after implant, the patient experienced exposed mesh, pain, infection, inflammation, adhesions, obstruction, perforation, abscess, draining sinus tract, serosal tearing, enterotomies, bilious drainage, ischemic enteropathy, submucosal edema, subserosal congestion, scarring, purulent fluid from wound, foreign body reaction, granulation tissue, fever, nausea, vomiting, weight loss, cramping, hematoma, and mental stress.Post-operative patient treatment included partial removal of mesh, medication, and small bowel resection.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional info: a1, a4, b6, b7, d4 (unique identifier (udi) #) & g1.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|
|
|